ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

$0.81
-0.01 (-1.20%)
As of Sep 28, 10:31 PM ET ·
Financial Highlights (FY 2026)
Revenue
13.29M
Net Income
57.70M
Gross Margin
53.7%
Profit Margin
434.2%
Rev Growth
-37.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.7% 53.7% 61.3% 61.3%
Operating Margin -218.9% -197.0% 22.2% 22.8%
Profit Margin 434.2% 412.5% 23.2% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 13.29M 21.09M 7.77M 7.02M
Gross Profit 7.13M 11.32M 4.76M 4.31M
Operating Income -29,088,053 -41,560,958 1.72M 1.61M
Net Income 57.70M 82.44M 1.80M 1.31M
Gross Margin 53.7% 53.7% 61.3% 61.3%
Operating Margin -218.9% -197.0% 22.2% 22.8%
Profit Margin 434.2% 412.5% 23.2% 18.7%
Rev Growth -37.0% -37.0% +3.8% -2.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 19.50M 20.13M
Total Equity — — 23.16M 25.61M
D/E Ratio — — 0.84 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -26,078,410 -39,330,829 2.38M 2.09M
Free Cash Flow — — 1.78M 1.31M